ADVERTISEMENT
Press release content from Newswire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Newswire
Press release content from Newswire. The AP news staff was not involved in its creation.

OptiMed Health Partners Offers Monoclonal Antibody Infusion Treatment for COVID Positive Patients

December 15, 2021 GMT
OptiMed Health Partners Offers Monoclonal Antibody Infusion Treatment for COVID Positive Patients
OptiMed Health Partners Offers Monoclonal Antibody Infusion Treatment for COVID Positive Patients
OptiMed Health Partners Offers Monoclonal Antibody Infusion Treatment for COVID Positive Patients

KALAMAZOO, Mich. - December 15, 2021 - ( Newswire.com )

OptiMed Health Partners offers monoclonal antibody infusion treatment for patients testing positive for the COVID-19 virus. Monoclonal antibodies are designed proteins that mimic the human immune system’s ability to fight off harmful viruses such as COVID-19. If you’ve tested positive for the COVID-19 virus, you may be eligible for a Monoclonal Antibody Infusion Treatment.

This treatment involves a one-time intravenous (IV) infusion and is designed to reduce the severity of the virus and shorten the symptoms in mild to moderate patients.

“Our patients value the fact that, here at OptiMed, we make every effort to make monoclonal antibody infusions against COVID-19 easily accessible in a timely manner”, says Jeff Lagonoy, PharmD., Clinical Pharmacist at OptiMed Specialty Pharmacy. “With these new therapies, there’s a limited time window that patients are eligible to receive care. We have a highly skilled multidisciplinary team that aims to piece together a care plan that is individualized and unique to every patient. Further, patients can now receive therapy in the comfort of their own home which provides convenience, and more importantly, reduces viral transmission within the community.”

ADVERTISEMENT

“Patients can now receive therapy in the comfort of their own home which provides convenience, and more importantly, reduces viral transmission within the community,” says Jeff Lagonoy, PharmD., Clinical Pharmacist at OptiMed Specialty Pharmacy.

To begin treatment, you should schedule a COVID-19 test by visiting www.optimedhp.com/test. OptiMed Health Partners offers PCR and Rapid Testing options at three convenient locations in Southwest Michigan. If you test positive, a member of our COVID-19 care team will reach out to coordinate the Monoclonal Antibody Treatment.

The treatment is offered with no out-of-pocket costs for the patient when using insurance and is free through the CARES Act for uninsured or Medicare patients.

About the COVID Testing Locations: COVID-19 KZOO, COVID-19 AZO, and COVID-19 PAW PAW offer PCR and Rapid testing conveniently located in Southwest Michigan. Book an appointment using their simple and easy scheduler and their team of professionals will help you stay safe throughout the year. Visit www.optimedhp.com/test to learn about all their locations, hours, and to book directly.

ADVERTISEMENT

About OptiMed: OptiMed Health Partners, headquartered in Kalamazoo, Michigan, is an independently owned and operated national health care organization. For more than 25 years, OptiMed leverages personalized attention to detail to deliver customized solutions that optimize patient outcomes while partnering with other health care organizations to usher in a new standard of excellence. To learn more about OptiMed’s innovative and personalized care, visit www.optimedhp.com.

Press Release Service by Newswire.com

Original Source: OptiMed Health Partners Offers Monoclonal Antibody Infusion Treatment for COVID Positive Patients